Switzerland
EPITERNA is a biotechnology startup based in Switzerland, with a strong focus on life-extending science. The company, founded in 2022, has recently received a significant €10.00M investment in a Corporate Round from Prima Materia as of 01 August 2023.
The company's mission is to create more meaningful time for people and their pets by tackling the challenges of ageing, a significant risk factor for diseases and functional decline. The team consists of ambitious scientists, engineers, veterinarians, and doctors all passionate about translating scientific discoveries into practical applications.
EPITERNA's goal is to develop affordable products that can effectively slow the ageing process, prevent age-related diseases, delay functional decline, and ultimately extend the lives of companion dogs and cats as well as humans.
With a strong emphasis on translating laboratory findings into real-world solutions, EPITERNA is well-positioned to make a substantial impact in the biotechnology space, addressing one of the most pressing health challenges of our time.
